healthcare News
Dexcom Dips Despite Q4 Beat as 2026 Outlook Signals Slower Growth
The continuous glucose monitor maker's full-year forecast of 11-13% growth falls short of some analyst expectations, overshadowing a strong quarterly performance.
OrthoPediatrics Slips as Q4 Revenue Miss Overshadows Strong 2026 Forecast
Shares fall despite the medical device maker projecting double-digit growth and $25 million in adjusted EBITDA, signaling investor concern over the near-term sales shortfall.
Esperion Surges After Forecasting Up to 38% Revenue Growth
Company projects strong 2025 sales for its cholesterol-lowering drugs, citing momentum from an expanded FDA label and robust prescription uptake.
Pharmacy Stocks Under Pressure as Amazon Enters Weight-Loss Drug Market
Shares in CVS and Walgreens face headwinds as the e-commerce giant begins offering popular GLP-1 drugs like Wegovy, intensifying competition in the lucrative pharmacy sector.
Amazon Enters Weight-Loss Market, Offers Wegovy Pill Via Pharmacy Unit
The move positions the e-commerce giant to compete in the lucrative GLP-1 drug market, leveraging its Amazon Clinic and logistics network to challenge established pharmacies.
Drug Retailers Pressured as Amazon Enters Wegovy Market
Tech giant's move into popular weight-loss treatments threatens to siphon market share from incumbents like CVS and Walgreens in the lucrative obesity drug sector.
Novo Nordisk Stock Climbs on Wegovy Pill Deal with Amazon Pharmacy
The Danish drugmaker is expanding access to its newly-approved oral weight-loss medication through the e-commerce giant, intensifying its rivalry with Eli Lilly.
Rhythm Pharma Posts 50% Revenue Growth, Eyes Key FDA Milestone
Preliminary results show $194 million in full-year sales for its obesity drug Imcivree, but shares fell as investors look ahead to a pivotal regulatory decision.